OMNIPAQUE (body cavity 240 and 300), a contrast agent often used for a diagnostic procedure called hysterosalpingography (HSG), should not be administered to individuals under certain specific circumstances due to potential risks or interference with the procedure. HSG is an X-ray procedure that looks at the inside of the uterus and fallopian tubes and the area around them.
Key Contraindications for OMNIPAQUE in Hysterosalpingography
It is crucial to avoid OMNIPAQUE (body cavity 240 and 300) for HSG if any of the following conditions apply:
- Pregnancy or Suspected Pregnancy: The use of OMNIPAQUE for HSG is contraindicated if there is an existing pregnancy or even a suspicion of pregnancy. This is to protect the developing fetus from potential harm.
- Menstruation or Imminent Menstruation: The procedure should not be performed during menstruation or when menstruation is expected to begin shortly. This reduces the risk of complications and ensures clearer diagnostic results.
- Recent Termination of Pregnancy: Individuals who have terminated a pregnancy within the past six months should not undergo HSG with OMNIPAQUE. This waiting period allows for proper uterine healing and reduces the risk of infection.
- Recent Gynecological Procedures: If a woman has undergone conization (a procedure to remove a cone-shaped piece of tissue from the cervix) or curettage (a procedure to remove tissue from the uterus) within the last 30 days, OMNIPAQUE for HSG should be avoided. This allows the body sufficient time to heal and minimizes the risk of infection or other complications.
- Signs of Infection: The presence of signs of infection in any part of the reproductive tract or related areas that would be involved in the hysterosalpingography procedure is a contraindication. Performing the procedure with an active infection could potentially spread the infection or worsen the patient's condition.
Summary of Contraindications for OMNIPAQUE (Body Cavity 240 and 300) in HSG
To provide a quick overview, here's a table summarizing the conditions under which OMNIPAQUE (body cavity 240 and 300) should not be used for hysterosalpingography:
| Condition | Reason for Contraindication (for HSG) |
|---|---|
| Pregnancy (or suspected) | Potential risk to the fetus. |
| Menstruation (or imminent) | Increased risk of complications and potential diagnostic interference. |
| Within 6 months after pregnancy termination | Allows for uterine healing and reduces infection risk. |
| Within 30 days after conization or curettage | Ensures adequate healing of the uterus/cervix and minimizes infection risk. |
| Presence of infection signs (e.g., reproductive tract) | Risk of spreading or worsening the infection. |
Always ensure that a healthcare professional evaluates your medical history and current condition before any medical procedure involving contrast agents like OMNIPAQUE. This ensures the safest and most effective diagnostic approach.
